...
首页> 外文期刊>Annals of hematology >IgG synthesis rate and anti-myelin oligodendrocyte glycoprotein antibody in CSF may be associated with the onset of CNS demyelination after haplo-HSCT
【24h】

IgG synthesis rate and anti-myelin oligodendrocyte glycoprotein antibody in CSF may be associated with the onset of CNS demyelination after haplo-HSCT

机译:CSF中的IgG合成率和抗髓鞘寡替肽糖蛋白抗体可能与HAPLO-HSCT后CNS脱髓鞘的开始相关

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Haploidentical hematopoietic stem cell transplant (haplo-HSCT) is an upfront and effective therapy for hematology patients, but it usually has many complications, such as neurological complications. As one of the neurological complications following haplo-HSCT, immune-mediated demyelinating diseases of the central nervous system (CNS) seriously affect a patient's quality of life. However, the incidence, risk factors, and pathogenesis of CNS demyelination are not very well understood. Thirty of the 1526 patients (1.96%) suffered from CNS demyelination. In univariate analysis, we found that blood-brain barrier (BBB) permeability and the CSF IgG synthesis index (IgG-Syn) were related to the occurrence of CNS demyelination (p 0.05). In a multivariate analysis, the IgG-Syn (OR = 1.017, 95% CI 1.003-1.031, p = 0.019) and CSF anti-myelin oligodendrocyte glycoprotein antibody (MOG.Ab) (OR = 12.059, 95% CI 1.141-127.458, p = 0.038) were independently associated with the onset of CNS demyelination. We also studied the possible pathogenesis of CNS demyelination. Immune reconstitution (the cell proportions of CD19(+) B cells, CD3(+) T cells, and CD4(+) T cells); the counts of leucocytes, lymphocytes, monocytes, and platelets; and the levels of immunoglobulins A, G, and M 30, 60, and 90 days after HSCT showed no significant differences between CNS demyelination and no demyelination (p 0.05). The probabilities of overall survival showed no significant differences between patients with and without demyelination (p 0.05). Only four deaths in 30 patients, but bringing projected survival to less than 20%.We imply that IgG-Syn and CSF MOG. Ab may be associated with the onset of CNS demyelination during 2 weeks of neurological symptoms in patients with brain or spinal cord MRI abnormality. Immune reconstitution may not be the pathogenesis of CNS demyelination.
机译:Haploidentical造血干细胞移植(HAPLO-HSCT)是血液学患者的前期和有效治疗,但通常具有许多并发症,例如神经系统并发症。作为HAPLO-HSCT后的神经系统并发症之一,中枢神经系统(CNS)的免疫介导的脱髓鞘疾病严重影响了患者的生活质量。然而,CNS脱髓鞘的发病率,危险因素和发病机制不是很好地理解。 1526名患者(1.96%)患有CNS脱髓鞘。在单变量分析中,我们发现血脑屏障(BBB)渗透率和CSF IgG合成指数(IgG-Syn)与CNS脱髓鞘的发生有关(P <0.05)。在多变量分析中,IgG-SYN(或= 1.017,95%CI 1.003-1.031,P = 0.019)和CSF抗髓鞘寡替肽糖蛋白抗体(MOG.AB)(或= 12.059,95%CI 1.141-127.458, P = 0.038)与CNS脱髓鞘的开始独立相关。我们还研究了CNS脱髓鞘的可能发病机制。免疫重建(CD19(+)B细胞,CD3(+)T细胞和CD4(+)T细胞的细胞比例);白细胞,淋巴细胞,单核细胞和血小板的数量;和HSCT在HSCT后的免疫球蛋白A,G和M 30,60和90天的水平显示CNS脱髓鞘之间没有显着差异,并且没有脱髓鞘(P&GT; 0.05)。整体存活的概率显示出患者和无脱髓鞘(P&GT; 0.05)之间没有显着差异。 30名患者中只有四个死亡,但将投影生存率带到少于20%。我们暗示IgG-SYN和CSF沼泽。 AB可能与脑或脊髓MRI异常患者的神经系统症状2周内的CNS脱髓鞘发生相关。免疫重建可能不是CNS脱髓鞘的发病机制。

著录项

  • 来源
    《Annals of hematology》 |2018年第8期|共8页
  • 作者单位

    Peking Univ Peoples Hosp Inst Hematol 11Xizhimen South St Beijing Peoples R China;

    Peking Univ Peoples Hosp Inst Hematol 11Xizhimen South St Beijing Peoples R China;

    Peking Univ Peoples Hosp Inst Hematol 11Xizhimen South St Beijing Peoples R China;

    Peking Univ Peoples Hosp Inst Hematol 11Xizhimen South St Beijing Peoples R China;

    Peking Univ Peoples Hosp Inst Hematol 11Xizhimen South St Beijing Peoples R China;

    Peking Univ Peoples Hosp Inst Hematol 11Xizhimen South St Beijing Peoples R China;

    Peking Univ Peoples Hosp Inst Hematol 11Xizhimen South St Beijing Peoples R China;

    Peking Univ Peoples Hosp Inst Hematol 11Xizhimen South St Beijing Peoples R China;

    Peking Univ Peoples Hosp Inst Hematol 11Xizhimen South St Beijing Peoples R China;

    Peking Univ Peoples Hosp Inst Hematol 11Xizhimen South St Beijing Peoples R China;

    Peking Univ Peoples Hosp Inst Hematol 11Xizhimen South St Beijing Peoples R China;

    Peking Univ Peoples Hosp Inst Hematol 11Xizhimen South St Beijing Peoples R China;

    Peking Univ Peoples Hosp Inst Hematol 11Xizhimen South St Beijing Peoples R China;

    Peking Univ Peoples Hosp Inst Hematol 11Xizhimen South St Beijing Peoples R China;

    Peking Univ Peoples Hosp Inst Hematol 11Xizhimen South St Beijing Peoples R China;

    Peking Univ Peoples Hosp Inst Hematol 11Xizhimen South St Beijing Peoples R China;

    Peking Univ Peoples Hosp Inst Hematol 11Xizhimen South St Beijing Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 血液及淋巴系疾病;
  • 关键词

    Antibody; CNS demyelination; Haploidentical stem cell transplantation;

    机译:抗体;CNS脱髓鞘;HAPLoidentical干细胞移植;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号